Merck Ditches Ph3 Migraine Program - July 29, 2011

Having trouble viewing this email? View in Browser.

Friday, July 29, 2011  |   |   |   |  The ADAPT 2011 Congress Features 5 tracks and 7 short courses exploring the relationship between biomarkers and the promise of personalized therapy, how circulating tumor cells (CTCs) could better track the progression of cancer, and adaptive trials that bring targeted therapies to market. Discount registration by July 22. To learn more, visit www.ADAPTcongress.com. •  Merck & Co., Inc. (MRK) Ditches Ph3 Migraine Program More... •  FDA Report Finds Shrink Wrap in Merck & Co., Inc. (MRK) Vaccines More... More Discontinuations News More Recalls and Warning News •  BioSyent Pharma Inc. Receives Health Canada Approval for New In-Licensed Topical Anesthetic More... •  Lannett Company, Inc. (LCI) Receives FDA Approval for Phentermine Resin Extended-Release Capsules, 15 mg and 30 mg More... More Drug Approval News •  FDA Issues Eisai Company, Ltd. (ESALY.PK) With "Refusal to File" Letter for Epilepsy Drug More... More BLA/NDA/ANDA News More IND News More MAA News •  ISTA Pharmaceuticals, Inc. (ISTA) Reports Results From the First of Two Trials in the REMURA(TM) Phase 3 Clinical Program for Dry Eye Disease More... •  Cancer Prevention Pharmaceuticals Receives Positive Scientific Advice From EMA for CPP-1X Phase III TRIAL in FAP More... •  Newron Pharmaceuticals (NWRN): Completion of Patient Enrollment in SETTLE, a Phase III Pivotal Clinical Trial of Safinamide in Advanced Parkinson's Disease More... •  BioMarin Pharmaceutical Inc. (BMRN) Provides Update on GALNS Phase 1/2 Extension Study (MOR-100) More... More Phase III News More Phase II News More Phase I News More Pre-Clinical News More Post-Approval News •  Bowel Cancer Risk Doubles for Men, Cancer Research UK Cambridge Research Institute Study More... •  Humabs Discovers The First Antibody To Neutralize Both Group 1 And Group 2 Influenza A Viruses, National Institute for Medical Research Study More... •  "Super Antibody" Fights Off Flu, National Institute for Medical Research Study More... •  New Therapy May Help People With Unexplained Symptoms of Pain, Weakness and Fatigue, University of Edinburgh Study More... •  ALR Technologies Inc. Release: Clinical Trial Follow-up Confirms Discontinuation of Intensive Blood Glucose Control Results in Reversal of A1c Improvement More... More General Clinical Research News 3rd Annual Partnerships in Clinical Trials Asia October 12-14, 2011 Grand Hyatt Shanghai The largest concentration of clinical decision makers specializing in clinical development, operations and outsourcing meet to provide you the opportunity to establish benchmarks, standards and next practices in the development and commercialization of products in a global marketplace. The agenda is filled with in-depth case studies on strategic partnering and effective outsourcing to ensure quality, control costs and accelerate cures to market. Please click here for more information. Advances in Drug-Diagnostic Co-Development • Understand the current regulatory environment for both diagnostics and drugs within the EU and the US and how these relate to their co-development. • Understand the biomarker discovery and validation process. • Using case studies discover how drugs and their companion diagnostics have already received approval in the US and EU. Click Here for More Information • BioCapital (Germantown, Maryland) Intrexon Corporation Senior Research Scientist - DNA Vaccines The qualified candidate will work closely with a team of scientists in the Animal Sciences Division (ASD) to develop novel approaches to meet therapeutic needs of companion and farm animals. • Biotech Beach (San Diego, California) Ardea Biosciences, Inc. Clinical Program Manager The overall responsibility will be to manage one or more phase 2-3 studies for our lead development program in Gout. The successful candidate will manage CROs, clinical sites, liaise with Finance and Project Management. Etc. • BioCapital (Columbia, Maryland) Pfizer Inc. Director, Clinical Research and Development The purpose of the position is to provide medical and scientific expertise to design, plan and implement preclinical and clinical development programs for investigational and marketed drugs. Etc. • BioMidwest (Lake Forest, Illinois) Hospira, Inc. Associate Director/Director Biologics Drug Product Formulation and Process Development Will be responsible for identifying and developing suitable Drug Product formulations and manufacturing processes for Hospira's growing portfolio of Global Biologics compounds. Etc. • Genetown (Cambridge, Massachusetts) Biogen Idec Associate Medical Director Fampridine Will lead the Global Medical Affairs Team activities associated with product life cycle management. The position is responsible for the support and execution of the Life Cycle Management plan as it pertains to Global Medical Affairs activities, etc. • Get Noticed! Add your resume to the BioSpace Career Center! • See more than 5,000 job postings in the BioSpace Career Center! Biotech Beach Career Fair Job seekers can spend a day with HR representatives and Hiring Managers from top biotech, pharma, medical device and diagnostics companies in the Southern California region. Candidates with a 4-year degree in the life sciences and a minimum of 2-years of industry related experience are invited to attend. (Equivalent work experience may be considered in lieu of a four-year college degree. PhD and Postdoc candidates welcome.) Exhibiting companies are recruiting for positions in areas such as: QA/QC, clinical research, engineering, manufacturing, biostatistics, clinical data management, chemistry, regulatory affairs, and research. Job seekers may register here. • Biotech Beach Career Fair, San Diego, CA September 22, 2011 • BioMidwest Career Fair, Chicago, IL October 4, 2011 • Pharm Country Career Fair, Bridgewater, NJ October 5, 2011 • Biotech Bay Career Fair, Burlingame, CA October 11, 2011 • Bio NC Career Fair, Durham, NC October 20, 2011 • BioCapital Beach Career Fair, Bethesda, MD November 1, 2011 • Genetown Career Fair, Cambridge, MA November 7, 2011 More information about BioSpace's Career Fairs BioSpace White Paper Biotech Career Fairs For Job Seekers 101: Control Your Experience By June Salvati, BioSpace Director of Events and Corporate Services •  New Vertex Pharmaceuticals (MA) (VRTX) Hepatitis Drug Shines Out of Gate, Beats Forecasts More... •  Cadence Pharmaceuticals, Inc. Reaffirms FDA-Approved Dosing Recommendations for OFIRMEV® (acetaminophen) Injection More... •  Teva Pharmaceutical Industries Limited (TEVA) Announces Launch of Camrese(TM) the Authorized Generic of Seasonique(R) More... More Drug Product News Hot Company Nektar Therapeutics 490 Discovery Drive Huntsville, Alabama 35806 U.S.A. Phone: 256-533-4201 Fax: 256-533-4805 Nektar Therapeutics is a biopharmaceutical company developing novel therapeutics based on its proprietary polymer conjugation technology platform. Post Your: News | Jobs | Company Profile | Event | Advertising / Sponsorship ClinicaSpace 6465 South Greenwood Plaza, Suite 400 Centennial, Colorado 80111 U.S.A. Phone: 877-277-7585 Fax: 800-595-2929 ClinicaSpace 90 New Montgomery Street, Suite 414 San Francisco, California 94105 U.S.A. Phone: 877-277-7585 Fax: 415-576-9217 Send questions and comments to the ClinicaSpace News Beat Team. Editor & Publisher: Rosemary Do Editorial & Production Staff: Lana Ho, Suvarna Sheth, Matt Thwin, Maysa Darwish ClinicaSpace.com - Clinical Trials. Clinical Research. Community. • ClinicaSpace is a registered trademark of BioSpace, Inc. • Please distribute this e-cast freely. • Credit any excerpts as follows: Copyright 2011 ClinicaSpace http://www.clinicaspace.com • While BioSpace and its agents used their best efforts in collecting and preparing the information published herein, we do not assume, and hereby disclaim, any liability for any loss or damage caused by errors or omissions, whether such errors or omissions resulted from negligence, accident or other causes. If someone forwarded this news to you and you'd like to receive your own copy FREE of charge, simply Subscribe here. Safely unsubscribe from ClinicaSpace.com e-mail at any time by managing your account here.